Evidence map›Paper›PMID 37796443›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023

A comparison of COVID-19 incidence rates across six European countries in 2021.

Michael Padget, Pauline Adam, Marina Dorfmuller, Clara Blondel, Ines Campos-Matos, Myriam Fayad, Alberto Mateo-Urdiales, David Mesher, Adriana Pistol, Javiera Rebolledo and 7 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Michael PadgetSanté Publique France, Saint Maurice, France.
Pauline AdamSanté Publique France, Saint Maurice, France.
Marina DorfmullerSanté Publique France, Saint Maurice, France.
Clara BlondelSanté Publique France, Saint Maurice, France.
Ines Campos-MatosCOVID Vaccines and Epidemiology, UK Health Security Agency, United Kingdom.
Myriam FayadSanté Publique France, Saint Maurice, France.
Alberto Mateo-UrdialesDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
David MesherInternational COVID Team, UK Health Security Agency, United Kingdom.
Adriana PistolNational Institute of Public Health Bucharest, Romania.
Javiera RebolledoDepartment of epidemiology and infectious diseases, Sciensano, Brussels, Belgium.
Flavia RiccardoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Maximilian RiessPublic Health Agency of Sweden, Stockholm, Sweden.
Lavinia Cipriana RusuNational Institute of Public Health Bucharest, Romania.
Didier CheSanté Publique France, Saint Maurice, France.
Bruno CoignardSanté Publique France, Saint Maurice, France.
COVID-19 Study groupThe members of the COVID-19 Study group are listed under Investigators.
COVID-19 Study Group members

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

International comparisons of COVID-19 incidence rates have helped gain insights into the characteristics of the disease, benchmark disease impact, shape public health measures and inform potential travel restrictions and border control measures. However, these comparisons may be biased by differences in COVID-19 surveillance systems and approaches to reporting in each country. To better understand these differences and their impact on incidence comparisons, we collected data on surveillance systems from six European countries: Belgium, England, France, Italy, Romania and Sweden. Data collected included: target testing populations, access to testing, case definitions, data entry and management and statistical approaches to incidence calculation. Average testing, incidence and contextual data were also collected. Data represented the surveillance systems as they were in mid-May 2021. Overall, important differences between surveillance systems were detected. Results showed wide variations in testing rates, access to free testing and the types of tests recorded in national databases, which may substantially limit incidence comparability. By systematically including testing information when comparing incidence rates, these comparisons may be greatly improved. New indicators incorporating testing or existing indicators such as death or hospitalisation will be important to improving international comparisons.

Indexed as

COVID-19EuropeHumansIncidenceItalyRomaniaCOVID-19Europeincidenceinternational comparisonssurveillance

Identifiers

PMID37796443
PMCPMC10557383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.